ClinicalTrials.Veeva

Find clinical trials for Kidney Disease in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Kidney Diseases
Chronic Renal Insufficiency
Chronic Kidney Failure
Renal Insufficiency
IGA Glomerulonephritis
Renal Cell Carcinoma
Diabetes Mellitus

Kidney Disease trials near Austin, TX, USA:

A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

to placebo in reducing the intensity of itch in advanced chronic kidney disease (CKD) patients with moderate-to-severe pruritus. Th...

Enrolling
Chronic Kidney Diseases
Pruritus
Drug: Difelikefalin 1 mg Oral Tablet
Drug: Placebo Oral Tablet

Phase 3

Cara Therapeutics
Cara Therapeutics

Austin, Texas, United States and 82 other locations

The purpose of this study is to measure the efficacy and safety of baxdrostat/dapagliflozin in participants ≥ 18 years of age with CKD and HTN. This...

Not yet enrolling
Chronic Kidney Disease and Hypertension
Drug: Baxdrostat/dapagliflozin
Drug: Dapagliflozin in combination with placebo

Phase 3

AstraZeneca
AstraZeneca

Austin, Texas, United States and 337 other locations

(for example heart attack and stroke) in people with cardiovascular disease, chronic kidney disease and inflammation.Parti...

Enrolling
Chronic Kidney Disease
Inflammation
Drug: Ziltivekimab C
Drug: Placebo (Ziltivekimab B)

Phase 3

Novo Nordisk
Novo Nordisk

San Marcos, Texas, United States and 943 other locations

This study is to evaluate the efficacy and safety of PLS240 in patients with hemodialysis-dependent end stage kidney disease (ESKD)...

Enrolling
End-stage Kidney Disease (ESKD)
Secondary Hyperparathyroidism
Drug: PLS240
Drug: Open-Label Extension PLS240

Phase 3

Pathalys Pharma

Austin, Texas, United States and 66 other locations

This is a prospective, randomized, multi-center clinical trial for chronic kidney disease (CKD) patients referred for creation of a...

Enrolling
Chronic Kidney Diseases
End Stage Renal Disease
Device: SelfWrap Bioabsorbable Perivascular Wrap
Procedure: Untreated AVF Control
VenoStent

Austin, Texas, United States of America and 6 other locations

The researchers are doing this study to see if semaglutide can slow down the growth and worsening of chronic kidney disease in peop...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Austin, Texas, United States and 406 other locations

of KBP-5074 in adult participants who have stage 3b/4 chronic kidney disease (CKD) (estimated glomerular filtration rate [eGFR] cal ...

Active, not recruiting
Chronic Kidney Diseases
Drug: KBP-5074
Drug: Placebo

Phase 3

KBP Biosciences

Austin, Texas, United States and 215 other locations

The objective of this study is to establish that the MB-102 transdermal fluorescence-measured Glomerular Filtration Rate (GFR) using the MediBeacon®...

Enrolling
Kidney Failure
Kidney Diseases
Device: MediBeacon Transdermal Glomerular Filtration Rate Measurement System (TGFR)
Drug: MB-102

Phase 3

MediBeacon

Austin, Texas, United States and 4 other locations

or more. People can take part if they have cardiovascular or chronic kidney disease. People who have at least 2 health problems rel...

Enrolling
Obesity
Drug: Placebo
Drug: survodutide

Phase 3

Boehringer Ingelheim
Boehringer Ingelheim

Austin, Texas, United States and 409 other locations

Contrast-Induced Nephropathy (CIN) can occur when patients with pre-existing kidney problems undergo procedures that use iodinated contrast ...

Active, not recruiting
Contrast Induced Nephropathy
Drug: Standard Therapy
Device: RenalGuard Therapy

Phase 3

CardioRenal Systems (RenalGuard Solutions)
CardioRenal Systems (RenalGuard Solutions)

Austin, Texas, United States and 29 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems